This webinar will be hosted live and available on-demand
Thursday, January 26, 2023
11:30 AM Eastern Time
Monoclonal antibody therapies are promising treatments for chronic disorders because they identify specific disease-causing molecules and train the immune system to clear them from the body. However, designing effective antibody-based therapeutics that elicit the appropriate response in patients is challenging. Scientists rely on cutting-edge technologies to develop and test every aspect of their candidate therapeutics.
In this webinar brought to you by The Scientist’s Creative Services Team, Gestur Vidarsson will highlight how analysis and engineering of antigen-specific immunoglobulin glycosylation affects the way antibodies modulate immune responses in a disease context.
Topics to be covered
- How naturally regulated variations of N-linked glycans in the IgG constant region influence effector functions
|
Gestur Vidarsson, PhD Professor of Immunoglobulin Biotherapeutics |
